About Us

Obsequio Pharmaceuticals Pvt. Ltd. Started its journey in 2022, with a commitment to heal, cure & provide general well being & happiness to people.

Team Obsequio is dedicated towards the Highest level of Compliance possible

Metabolic Disorders today is gradually turning into be an Epidemic in India. Hypertension, Dyslipidemia & Diabetes are the 3 Major silent killers affecting other major organ damage. With the vision of becoming a Trusted & Admirable partner to the society in treating these metabolic disorders, Obsequio offers therapies for Hypertension, Diabetes & related Complications

Our Contract Manufacturing Associate is having well equipped GMP Certified, FDA Licensed Production Unit; based out of 3 Continents- Asia, Europe & Africa.